0.8361
price up icon0.23%   0.0019
after-market Dopo l'orario di chiusura: .83 -0.0061 -0.73%
loading
Precedente Chiudi:
$0.8342
Aprire:
$0.8342
Volume 24 ore:
2.91M
Relative Volume:
0.72
Capitalizzazione di mercato:
$244.17M
Reddito:
-
Utile/perdita netta:
$-63.08M
Rapporto P/E:
-3.0967
EPS:
-0.27
Flusso di cassa netto:
$-72.53M
1 W Prestazione:
-10.17%
1M Prestazione:
+14.86%
6M Prestazione:
-14.87%
1 anno Prestazione:
-47.42%
Intervallo 1D:
Value
$0.808
$0.8765
Intervallo di 1 settimana:
Value
$0.808
$1.01
Portata 52W:
Value
$0.515
$1.979

Ocugen Inc Stock (OCGN) Company Profile

Name
Nome
Ocugen Inc
Name
Telefono
484-328-4701
Name
Indirizzo
11 GREAT VALLEY PARKWAY, MALVERN, PA
Name
Dipendente
95
Name
Cinguettio
@Ocugen
Name
Prossima data di guadagno
2025-05-02
Name
Ultimi documenti SEC
Name
OCGN's Discussions on Twitter

Confronta OCGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OCGN
Ocugen Inc
0.8361 271.82M 0 -63.08M -72.53M -0.27
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Ocugen Inc Stock (OCGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-10-15 Iniziato Maxim Group Buy
2023-03-01 Aggiornamento Chardan Capital Markets Neutral → Buy
2022-08-23 Iniziato Mizuho Buy
2022-06-15 Ripresa ROTH Capital Buy
2022-06-02 Iniziato Cantor Fitzgerald Overweight
2021-07-26 Iniziato Noble Capital Markets Outperform
2021-06-11 Downgrade ROTH Capital Buy → Neutral
2021-05-07 Downgrade Cantor Fitzgerald Overweight → Neutral
2021-02-09 Downgrade Chardan Capital Markets Buy → Neutral
2021-02-04 Aggiornamento H.C. Wainwright Neutral → Buy
Mostra tutto

Ocugen Inc Borsa (OCGN) Ultime notizie

pulisher
May 29, 2025

FDA awards Ocugen drug with Rare Pediatric Disease Designation - Pennsylvania Business Report -

May 29, 2025
pulisher
May 28, 2025

Ocugen’s Gene Therapy OCU410ST Nets Rare Pediatric Disease Designation for ABCA4-Associated Retinopathies - CGTLive®

May 28, 2025
pulisher
May 28, 2025

Ocugen wins FDA rare pediatric disease status for genetic eye disorder treatment - MSN

May 28, 2025
pulisher
May 27, 2025

FDA grants Ocugen rare pediatric disease designation as voucher program remains in limbo - The Business Journals

May 27, 2025
pulisher
May 27, 2025

Ocugen Gets FDA Rare Pediatric Disease Label for OCU410ST - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

Ocugen (OCGN) Gains Rare Pediatric Disease Status for Eye Therap - GuruFocus

May 27, 2025
pulisher
May 27, 2025

FDA grants Ocugen’s OCU410ST rare pediatric disease status By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST—Modifier Gene Therapy for the Treatment of Stargardt Disease - Ocugen

May 27, 2025
pulisher
May 27, 2025

Ocugen Announces Rare Pediatric Disease Designation Granted for - GuruFocus

May 27, 2025
pulisher
May 27, 2025

FDA grants Ocugen’s OCU410ST rare pediatric disease status - Investing.com

May 27, 2025
pulisher
May 27, 2025

FDA Grants Rare Pediatric Disease Designation to OCU410ST from Ocugen (OCGN) | OCGN Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Ocugen receives Rare Pediatric Disease Designation for OCU410ST - TipRanks

May 27, 2025
pulisher
May 27, 2025

Ocugen Announces Rare Pediatric Disease Designation Granted - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

FDA Backs Ocugen's Revolutionary Gene Therapy for Rare Childhood BlindnessNo Current Treatment Exists - Stock Titan

May 27, 2025
pulisher
May 27, 2025

Northern Trust Corp Acquires 227,150 Shares of Ocugen, Inc. (NASDAQ:OCGN) - Defense World

May 27, 2025
pulisher
May 20, 2025

Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish - MSN

May 20, 2025
pulisher
May 19, 2025

Ocugen, Inc. (NASDAQ:OCGN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 16, 2025

Ocugen Reports Progress in Q1 2025 with Advancements in Gene Therapy - MSN

May 16, 2025
pulisher
May 16, 2025

Tower Research Capital LLC TRC Has $32,000 Position in Ocugen, Inc. (NASDAQ:OCGN) - Defense World

May 16, 2025
pulisher
May 15, 2025

Ocugen Provides Business Update with First Quarter 2025 Financial Results - ADVFN

May 15, 2025
pulisher
May 15, 2025

Noble Financial Predicts Ocugen’s Q2 Earnings (NASDAQ:OCGN) - Defense World

May 15, 2025
pulisher
May 14, 2025

Ocugen to Host Q1 2025 Earnings Call and Business Update on May 9 - MSN

May 14, 2025
pulisher
May 13, 2025

Ocugen stock price target cut to $7 by H.C. Wainwright - Investing.com Canada

May 13, 2025
pulisher
May 13, 2025

Ocugen (NASDAQ:OCGN) Receives Buy Rating from Chardan Capital - Defense World

May 13, 2025
pulisher
May 12, 2025

Ocugen (OCGN) Receives Ongoing "Buy" Rating from Chardan Capital - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Ocugen (OCGN) Maintains 'Buy' Rating Despite Price Target Adjust - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Ocugen (OCGN) Price Target Reduced by H.C. Wainwright | OCGN Sto - GuruFocus

May 12, 2025
pulisher
May 12, 2025

The Analyst Verdict: Ocugen In The Eyes Of 5 Experts - Benzinga

May 12, 2025
pulisher
May 12, 2025

Ocugen outlines 2025 milestones for gene therapy programs with BLA filings on track - MSN

May 12, 2025
pulisher
May 11, 2025

Barclays PLC Decreases Holdings in Ocugen, Inc. (NASDAQ:OCGN) - Defense World

May 11, 2025
pulisher
May 10, 2025

Ocugen, Inc. (NASDAQ:OCGN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 10, 2025

Ocugen: Q1 Earnings Snapshot - New Haven Register

May 10, 2025
pulisher
May 10, 2025

Ocugen Inc (OCGN) Q1 2025 Earnings Call Highlights: Strategic Advances in Gene Therapy Amid ... - Yahoo

May 10, 2025
pulisher
May 10, 2025

Earnings call transcript: Ocugen’s Q1 2025 loss narrows, stock rises By Investing.com - Investing.com India

May 10, 2025
pulisher
May 10, 2025

Ocugen Inc (OCGN) Q1 2025 Earnings Call Highlights: Strategic Ad - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Earnings call transcript: Ocugen’s Q1 2025 loss narrows, stock rises - Investing.com

May 10, 2025
pulisher
May 10, 2025

Ocugen’s Q1 2025: Progress in Gene Therapy Trials - TipRanks

May 10, 2025
pulisher
May 09, 2025

Ocugen Inc’s Earnings Call: Optimism Amid Financial Challenges - TipRanks

May 09, 2025
pulisher
May 09, 2025

Ocugen Provides Business Update with First Quarter 2025 Financia - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Ocugen Q1 2025 Earnings Call Transcript - MarketBeat

May 09, 2025
pulisher
May 09, 2025

Ocugen (OCGN) Reveals Strong Q1 Revenue Growth and Strategic Cli - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish By Stocktwits - Investing.com India

May 09, 2025
pulisher
May 09, 2025

Ocugen (OCGN) Reveals Strong Q1 Revenue Growth and Strategic Clinical Advancements | OCGN Stock News - GuruFocus

May 09, 2025

Ocugen Inc Azioni (OCGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Capitalizzazione:     |  Volume (24 ore):